Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy.
10.4046/trd.2009.67.4.281
- Author:
Jae Hoon SONG
1
;
Ki Suck JUNG
;
Moon Won KANG
;
Do Jin KIM
;
Hyunjoo PAI
;
Gee Young SUH
;
Tae Sun SHIM
;
Joong Hyun AHN
;
Chul Min AHN
;
Jun Hee WOO
;
Nam Yong LEE
;
Dong Gun LEE
;
Mi Suk LEE
;
Sang Moo LEE
;
Yeong Seon LEE
;
Hyukmin LEE
;
Doo Ryeon CHUNG
Author Information
1. Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. songjh@skku.edu
- Publication Type:Practice Guideline ; Review
- Keywords:
Pneumonia;
Practice guideline;
Anti-bacterial agents
- MeSH:
Adult;
Anti-Bacterial Agents;
Communicable Diseases;
Humans;
Joints;
Korea;
Pneumonia;
Tuberculosis
- From:Tuberculosis and Respiratory Diseases
2009;67(4):281-302
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The successful treatment of community-acquired pneumonia requires appropriate, empirical antimicrobial therapy. The etiology and antimicrobial susceptibility of major pneumonia pathogens can differ by country. Therefore, the ideal treatment guidelines for community-acquired pneumonia should be based on the studies performed in each country. We developed a treatment guideline for community-acquired pneumonia for immunocompetent adults in Korea. This guideline was developed by the joint committee of the Korean Society for Chemotherapy, the Korean Society of Infectious Diseases, and the Korean Academy of Tuberculosis and Respiratory diseases.
